Browse the evidence

Sustained weight loss of 10% or more through combinatorial lifestyle, medical, or surgical interventions is the most effective strategy for preventing hepatocellular carcinoma (HCC) by reversing or halting the progression of metabolic dysfunction-associated fatty liver disease (MAFLD).

To lower your risk of liver cancer, you need to reduce your body weight by at least 10%. This is best achieved by combining a calorie-restricted diet (focusing on plants and limiting sugars/fats) with regular exercise (150 minutes/week). If lifestyle changes aren't enough, medical therapies or bariatric surgery are highly effective options that provide durable weight loss and reverse liver disease. The goal is sustained weight reduction, not just short-term dieting.

Resistance exercise training (RET) significantly improves lean body mass (LBM) retention during very-low-energy diets (VLEDs) compared to diet-only interventions, whereas aerobic exercise training (AET) yields conflicting or negligible results.

If you are on a very low-calorie diet, prioritize resistance training over cardio if your goal is to keep your muscle. Cardio might not help preserve muscle and results vary. Resistance training is the best tool available to stop muscle loss during rapid weight loss, even if you feel tired.

For patients on GLP-1 receptor agonists, adequate protein intake and strength training are necessary to mitigate muscle mass loss associated with rapid weight loss, while dietary adjustments (smaller, lower-fat meals, fiber) help manage gastrointestinal side effects.

If you are taking GLP-1 medication, prioritize protein and strength training to protect your muscles. Manage GI side effects by eating smaller, lower-fat meals and using fiber supplements if needed. Avoid high-intensity exercise if it exacerbates nausea or diarrhea.

A 6-month lifestyle-medicine intervention combining a low-carbohydrate diet, resistance/aerobic exercise, and medication withdrawal achieves diabetes remission (A1C <6.5%) in approximately 60-65% of type 2 diabetic patients, regardless of whether they are lean (BMI <25 kg/m2) or obese (BMI ≥25 kg/m2).

If you have Type 2 Diabetes, remission is possible regardless of your weight. A structured 6-month program involving a temporary low-carb/low-calorie diet, regular resistance and aerobic exercise, and the supervised withdrawal of diabetes medications can achieve remission in about 60% of patients. This applies to both lean and obese individuals, suggesting that metabolic health improvements (like lower fasting glucose and visceral fat) are more critical than weight loss alone.

Contemporary obesity management medications (OMMs) like semaglutide and tirzepatide cause significant lean mass loss (25-40% of weight lost), necessitating specific lifestyle interventions (resistance training and adequate protein) to mitigate muscle loss and maintain metabolic health.

If you are taking a GLP-1 or similar weight loss medication, expect to lose some muscle along with fat. To protect your strength and metabolism, prioritize resistance training and ensure you are eating enough protein. These lifestyle steps are critical complements to the medication.

HMB (3 g/day) and Creatine (5 g/day) supplementation, combined with resistance training, helps preserve lean body mass and strength during GLP-1RA-induced weight loss.

If you are doing resistance training, consider taking 3g of HMB and 5g of Creatine daily. These supplements help protect your muscles and strength while you lose weight on GLP-1RA medication.

Combining GLP-1 based therapies (GBTs) with individualized nutritional and physical activity interventions is necessary to preserve lean muscle mass, mitigate gastrointestinal adverse effects, and optimize long-term weight management outcomes.

When starting a GLP-1 medication like Ozempic or Wegovy, do not rely on the drug alone. You must actively manage your diet and exercise. Aim for 1.2 to 1.5 grams of protein per kilogram of your body weight every day, and engage in resistance training (weight lifting) at least twice a week alongside 150 minutes of moderate cardio. If you experience nausea, eat smaller, more frequent meals and stay hydrated. This combination prevents muscle loss and helps you stick with the treatment.

A structured, telehealth-based Individualized Virtual Integrative Medicine (IVIM) protocol combined with semaglutide (branded or compounded) significantly enhances weight loss outcomes, achieving an average 19.5% total body weight reduction at 52 weeks.

If you have obesity and are using semaglutide, sticking to a structured care plan that includes regular medical check-ins, coaching, and app-based tracking can lead to significant weight loss (approx. 20% over a year). This holds true whether you use the branded version or a compounded version, provided you maintain continuous therapy without gaps. The key is adherence and managing side effects through professional support.

Integrating GLP-1 receptor agonist therapy with intermittent fasting and protein-optimized resistance training preserves lean mass and improves metabolic outcomes more effectively than either intervention alone.

Start GLP-1 therapy as prescribed to manage appetite. Use this reduced hunger to gradually adopt time-restricted eating (e.g., 16:8). Prioritize high-protein meals during your eating window and engage in resistance training 2-3 times per week to protect muscle. This combination aims to maximize fat loss while minimizing muscle loss and long-term drug costs.

A comprehensive, team-based lifestyle intervention combining dietary education, supervised exercise, and behavioral counseling yields moderate but significant weight loss (mean 4.8 kg) and improved body composition in obese adults over one year.

To lose weight sustainably, combine dietary changes with regular exercise and behavioral support. This specific program used 25 sessions over a year, including medical check-ins, dietitian advice, cooking classes, and supervised exercise. The key was not just the activity, but the structured support and motivation to maintain these changes long-term.

Combining GLP-1 pharmacotherapy with promyogenic agents (e.g., bimagrumab, enobosarm), structured resistance exercise, and targeted nutrition (protein/HMB) mitigates lean mass loss and improves functional outcomes compared to GLP-1 monotherapy.

Do not rely on GLP-1 medication alone. To protect your muscles and strength, you must combine your medication with resistance exercise, ensure you are eating enough protein, and ask your doctor about emerging combination therapies like promyogenic agents that specifically target muscle preservation.

Achieving a BMI <25 kg/m2 is associated with a significantly greater reduction in predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk compared to maintaining a BMI ≥25 kg/m2, regardless of whether the weight loss is achieved via tirzepatide or placebo.

If you have obesity or overweight, aiming for a BMI below 25 kg/m2 may offer greater protection against heart disease and stroke than stopping at a smaller weight loss. This target is increasingly achievable with modern medications like tirzepatide, which help achieve significant weight reduction. While current guidelines suggest 5-15% weight loss, this analysis indicates that reaching a 'normal' BMI might provide additional cardiovascular benefits, particularly for those with existing risk factors like high blood pressure or NAFLD.

Combined aerobic and resistance exercise provides additive or synergistic benefits for MASLD by simultaneously enhancing oxidative metabolism and increasing skeletal muscle mass.

For the best results, combine aerobic exercise (like brisk walking or cycling) with resistance training (like weight lifting). Aim for 150-300 minutes of moderate aerobic activity and 2-3 resistance sessions per week. This combination targets both your liver's fat processing and your muscle's ability to use energy, providing a comprehensive metabolic benefit.

Resistance training reduces the loss of lean body mass during diet-induced weight loss, particularly in older adults with obesity.

If you are losing weight, include resistance training to protect your muscle mass. This is especially important if you are older. Aerobic exercise alone may not preserve muscle as effectively as resistance training.

Whole-food, nutrient-dense diets that reduce ultra-processed food consumption are effective for weight management and metabolic health.

Focus on eating whole, nutrient-dense foods and minimize ultra-processed foods. This approach supports weight management and metabolic health through energy balance, hormonal regulation, and gut microbiota effects.

A 45-day very-low-calorie ketogenic diet (VLCKD) incorporating whey protein improves muscle strength preservation and yields a healthier gut microbiota profile (increased Bacteroidetes, decreased Firmicutes) compared to vegetable or animal protein sources.

If you are doing a strict low-calorie ketogenic diet, choose whey protein as your primary supplement source. This study suggests it helps preserve muscle strength better than animal proteins (meat/fish/eggs) and promotes a healthier gut bacteria balance. Aim for about 90g of protein daily spread across 5 meals, keeping total calories around 780, and monitor your ketosis via urine strips to ensure you stay in the metabolic state.

Combining resistance training with a caloric deficit maximizes fat mass loss in overweight/obese premenopausal women compared to diet or resistance training alone.

To lose the most fat while keeping your muscle, combine a moderate caloric deficit with a high-protein diet and resistance training. Do not skip the weights just because you are dieting; they are crucial for preserving your metabolic engine and lean tissue. Aim for 3 days of strength training per week, focusing on compound movements with 10-12 reps, and ensure you are eating enough protein (around 1.4g per kg of body weight) to support your muscles during the deficit.

Post-bariatric exercise training yields approximately 1.94 kg of additional weight loss compared to surgery alone, with aerobic-resistance combinations and starting exercise ≥1 year post-surgery producing the greatest effects.

If you have had bariatric surgery, adding exercise to your routine will help you lose more weight and improve your physical function compared to relying on surgery and diet alone. For the best results, wait at least one year after surgery to start a structured exercise program, and combine aerobic activities (like walking or cycling) with resistance training (weight lifting). Aim for 1.3 to 4 hours of exercise per week, spread over 2-3 sessions.

Alternate day fasting (ADF) combined with a low-carbohydrate diet (30% carbs) produces significant weight loss and improves metabolic risk factors (LDL, blood pressure, fasting insulin) in adults with obesity.

To lose weight and improve metabolic health using this method, alternate days of strict 600-kcal fasting (using meal replacements) with 1000-kcal feast days (using meal replacements plus low-carb food). Ensure your diet is low in carbohydrates (30% of calories) on both types of days. This protocol was shown to reduce weight by ~6% and improve LDL, blood pressure, and insulin over 6 months in obese adults.

Combined exercise and low carbohydrate ketogenic diet interventions significantly reduce waist circumference and triglycerides in overweight and obese individuals compared to control groups.

If you are overweight or obese, combining regular moderate-to-vigorous exercise (about 4 times a week for an hour) with a low-carbohydrate ketogenic diet (less than 50g carbs, high fat) can help reduce your waist size and triglyceride levels. You do not need to restrict calories, which might make it easier to stick with. While other body composition metrics like total weight or BMI might not change significantly, the reduction in waist circumference is a clinically meaningful improvement for chronic disease risk.

An 8-week Very Low-Calorie Ketogenic Diet (VLCKD) significantly reduces liver fat accumulation (measured by CAP and FLI) and improves metabolic biomarkers in overweight/obese subjects with NAFLD.

To improve liver health, follow an 8-week VLCKD protocol strictly. Consume under 800 calories daily with only 20-50g of carbs. Use meal replacements initially, then transition to one real protein meal. Ensure you take micronutrient supplements and drink at least 2 liters of water daily. This approach targets liver fat directly.

A multiphasic very-low-calorie ketogenic diet (VLCKD) program significantly reduces body weight, waist circumference, and cardiometabolic risk markers (including insulin resistance, blood pressure, and lipid profiles) in women with overweight or obesity when implemented in a real-world outpatient setting.

For women with overweight or obesity, a structured, medically supervised very-low-calorie ketogenic diet program over 24 weeks can significantly reduce body weight, waist size, and improve key health markers like insulin resistance and blood pressure. The program uses specific meal replacements and supplements, divided into active and stabilization phases. While strict adherence is challenging and some individuals may see an increase in LDL cholesterol, the overall cardiovascular risk profile tends to improve. Regular monitoring of liver, kidney, and lipid functions is recommended to ensure safety and tailor the approach.

Low-intensity endurance training targeted at maximal lipid oxidation (LIPOXmax) maintains significant weight loss over 3 years, whereas low-fat diet alone fails to sustain weight loss after 1 year.

To lose weight and keep it off long-term, try low-intensity endurance exercise (like cycling or walking) where you can still hold a conversation but are working hard enough to burn fat. Aim for about 45 minutes, 3 times a week. Don't worry about burning massive calories; the key is training your body to use fat efficiently and potentially reducing your appetite. Consistency and regular check-ins with a professional are crucial for maintaining these habits over years.

A multimodal metabolic health intervention emphasizing therapeutic carbohydrate reduction (TCR) and intermittent fasting, supported by remote monitoring and coaching, produces robust 1-year weight loss (mean 15.5%) and significant medication deprescription in patients with obesity and type 2 diabetes.

If you have obesity or type 2 diabetes, consider a structured program that combines a low-carbohydrate diet (under 30g carbs/day) with remote health monitoring and coaching. This approach can lead to significant weight loss (around 15%) and may allow you to reduce or stop diabetes and blood pressure medications under medical supervision, potentially saving money and avoiding medication side effects.